CWAN Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin BK Q1 2026 Earnings EPS Surpasses Estimates by 133 Revenue Details Not Disclosed Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage GIL Q1 2026 Earnings EPS Beats Estimates with 734 Surprise IMVT Q1 2026 Earnings EPS Misses Estimates as Clinical Investment Intensifies YALA Q1 2026 Earnings EPS of 016 Reported Stock Rises Amid Limited Disclosures